Skip to content

Tango Therapeutics, Inc.

TNGX · XNAS

CIK 1819133fmd_0Q1P3J0WFT5VGFHV3V7XP5NTSDManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods

Loading statement
Tango Therapeutics, Inc. (TNGX) financial statements · FinancialMD